Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report
Top Cited Papers
- 1 September 2007
- journal article
- review article
- Published by Elsevier BV in Value in Health
- Vol. 10 (5), 326-335
- https://doi.org/10.1111/j.1524-4733.2007.00186.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003Value in Health, 2005
- Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural AdaptationValue in Health, 2005
- Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?Value in Health, 2005
- Evidence-Based And Value-Based Formulary GuidelinesHealth Affairs, 2004
- Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001Value in Health, 2003
- A new system for grading recommendations in evidence based guidelinesBMJ, 2001
- Current methods of the U.S. Preventive Services Task Force: A review of the processAmerican Journal of Preventive Medicine, 2001
- Evidence-Based Medicine and Practice Guidelines: An OverviewCancer Control, 2000
- Evidence based medicine: what it is and what it isn'tBMJ, 1996
- Users' Guides to the Medical LiteratureJAMA, 1995